ReviewHeliyon2024
Advances in stabilization of metallic nanoparticle with biosurfactants- a review on current trends.
Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Nanoparticle based drug delivery systems improve antimalarial efficacy and vaccine performance in African research and clinical settings.Discover nano · 2026Review
- Biosurfactants as Stabilizers of Silver Nanoparticles: A Sustainable Approach for Antimicrobial Applications.Microorganisms · 2026Article
- From the Problem of Corrosion to Green Solutions: The Role of Biosurfactants as Anti-Corrosion Agents.Materials (Basel, Switzerland) · 2026Review
- Optimization and characterization of zinc oxide nanoparticles synthesized with the assistance ofBiotechnology notes (Amsterdam, Netherlands) · 2026Article
- AuNP-Containing Hydrogels Based on Arabinogalactan and κ-Carrageenan with Antiradical Activity.Gels (Basel, Switzerland) · 2025Article
- Design and Characterization of PAA/CHI/Triclosan Multilayer Films with Long-Term Antibacterial Activity.Polymers · 2025Article
- Sophorolipids as anticancer agents: progress and challenges.Discover oncology · 2025Review
- Nanoparticle-Encapsulated Plant Polyphenols and Flavonoids as an Enhanced Delivery System for Anti-Acne Therapy.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Preparation and characterization of immobilized indole-3-butyric acid on silver-cerium oxide nanoparticles for improving its stability and utilization in the study of plant root formation indices.Frontiers in plant science · 2025Article
- Green synthesis of zinc oxide nanoparticles using Catunaregam spinosa (Thunb.) triveng for biologicals applications.PloS one · 2025Article
- Recent Advances in Photodynamic Therapy: Metal-Based Nanoparticles as Tools to Improve Cancer Therapy.Pharmaceutics · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, research based on new biomaterials for stabilizing metallic nanoparticles has increased due to their greater environmental friendliness and lower health risk. Their stability is often a critical factor influencing their performance and shelf life. Nowadays, the use of biosurfactants is gaining interest due to their sustainable advantages. Biosurfactants are used for various commercial and industrial applications such as food processing, therapeutic applications, agriculture, etc. Biosurfactants create stable coatings surrounding nanoparticles to stop agglomeration and provide long-term stability. The present review study describes a collection of important scientific works on stabilization and capping of metallic nanoparticles as biosurfactants. This review also provides a comprehensive overview of the intrinsic properties and environmental aspects of metal nanoparticles coated with biosurfactants. In addition, future methods and potential solutions for biosurfactant-mediated stabilization in nanoparticle synthesis are also highlighted. The objective of this study is to ensure that the stabilized nanoparticles exhibit biocompatible properties, making them suitable for applications in medicine and biotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.